| Dec 7 2018 |
USDA Issues Final Rule Setting a Uniform Compliance Date for Food Labeling Regulations |
Keller and Heckman LLP |
| Dec 6 2018 |
FDA Reexamining Communication Practices with Investigational New Drug Sponsors |
Epstein Becker & Green, P.C. |
| Dec 6 2018 |
Significant FDA Digital Health Policy Development for Prescription Drug Sponsors |
Covington & Burling LLP |
| Dec 6 2018 |
CMS Proposes Changes to Lower Drug Prices |
Foley & Lardner LLP |
| Dec 5 2018 |
Michigan Employer Action Steps for Recreational Marijuana |
Barnes & Thornburg LLP |
| Dec 5 2018 |
FDA Alerts Consumers to Dog Food Recalls For Potentially Toxic Vitamin D Exposure |
Keller and Heckman LLP |
| Dec 5 2018 |
New Medicare Advantage and Part D Drug Pricing Proposed Rule |
Mintz |
| Dec 4 2018 |
Pharmaceutical and Technology Industry Innovation Growth at Stake in Helsinn Healthcare v. Teva |
ArentFox Schiff LLP |
| Dec 4 2018 |
EC Amends REACH to Require Information on Nanomaterials |
Bergeson & Campbell, P.C. |
| Dec 4 2018 |
Clarification of OSHA Rule Regarding Drug Testing and Safety Incentive Programs |
Polsinelli PC |
| Dec 4 2018 |
FDA Develops Educational Module on Menu Labeling |
Keller and Heckman LLP |
| Dec 4 2018 |
Will Hemp-Derived CBD Be Fully Legal with Passage of the 2018 Farm Bill? Not Quite… |
Wilson Elser Moskowitz Edelman & Dicker LLP |
| Dec 3 2018 |
EFSA Releases Evaluation of Cyanide Risk from Foods |
Keller and Heckman LLP |
| Nov 30 2018 |
7th Circuit Issues Lebamoff Opinion |
McDermott Will & Schulte LLP |
| Nov 30 2018 |
In re Accutane Litigation: A Victory for Pharmaceutical Companies on Choice of Law and Label Warnings |
Sills Cummis & Gross P.C. |
| Nov 30 2018 |
OIG Work Plan Monthly Updates (July, August, September, October 2018) |
von Briesen & Roper, s.c. |
| Nov 30 2018 |
FDA Finds High Levels of Heavy Metals in Kratom Products |
Keller and Heckman LLP |
| Nov 29 2018 |
HRSA Establishes January 1, 2019 Effective Date for 340B Ceiling Price and Civil Monetary Penalty Rule |
Epstein Becker & Green, P.C. |
| Nov 29 2018 |
CMS Issues Proposed Rule on Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses |
Sheppard, Mullin, Richter & Hampton LLP |
| Nov 28 2018 |
California’s Proposition 12 Animal Welfare Measure Wins Big – Requires Cage-Free Eggs by 2022 |
Keller and Heckman LLP |
| Nov 28 2018 |
November 2018 Regulatory Developments |
Giordano, Halleran & Ciesla, P.C. |
| Nov 27 2018 |
Missouri Goes Green: What Employers Need to Know About the State’s New Medical Marijuana Law |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Nov 27 2018 |
Multistate E. Coli Outbreak Linked to Romaine Lettuce Grown in California |
Keller and Heckman LLP |
| Nov 26 2018 |
Can I Bring Cannabis from Canada Home? |
Epstein Becker & Green, P.C. |
| Nov 26 2018 |
EFSA Opens Public Consultation on Draft TTC Guidance |
Keller and Heckman LLP |
| Nov 26 2018 |
FDA Action Against Dietary Supplements Containing Tianeptine Signals Renewed Focus on Protecting Consumers from Dietary Supplements with Unauthorized Drug Claims |
Keller and Heckman LLP |
| Nov 21 2018 |
FDA and CDC Investigate Multistate E. coli Outbreak Linked to Romaine |
Keller and Heckman LLP |
| Nov 21 2018 |
Mechanism Needed to Delist FCNs for Non-Safety Reasons, Says FDA |
Keller and Heckman LLP |
| Nov 20 2018 |
Blog Series Part 7: CMS Proposed Rule on Policy and Technical Changes to the Medicare Advantage, Medicare Prescription Drug Benefit, Medicaid Fee-For-Service, and Medicaid Managed Care Programs for 2020 and 2021 |
Sheppard, Mullin, Richter & Hampton LLP |
| Nov 20 2018 |
FDA Loosens the Reins on Informed Consent Requirements for Certain Clinical Studies |
Epstein Becker & Green, P.C. |
| Nov 20 2018 |
FDA Authorizes Qualified Health Claim for Oleic Acid |
Keller and Heckman LLP |
| Nov 20 2018 |
U.S. Canada-RCC Stakeholder Forum to include EPA-PMRA Breakout Session |
Bergeson & Campbell, P.C. |
| Nov 19 2018 |
Important Details Remain Unsettled Following USDA and FDA Announcement of Decision to Jointly Regulate Cell-Cultured Meat |
Keller and Heckman LLP |
| Nov 19 2018 |
FDA Announces Plan for Restricting Access to Flavored E-Cigarettes |
Stark & Stark |
| Nov 16 2018 |
One Court Declines to Rule that Pharmacy Prescription Calls are Per Se Protected by the Emergency Purposes Exception, Rejecting Cases Holding Otherwise |
Faegre Drinker |
